Diabetic nephropathy: diagnosis and treatment
D Fineberg, KAM Jandeleit-Dahm… - Nature Reviews …, 2013 - nature.com
Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
Diabetic nephropathy: Diagnosis and treatment
D Fineberg, KAM Jandeleit-Dahm… - Nature Reviews …, 2013 - research.monash.edu
Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
[引用][C] Diabetic nephropathy: diagnosis and treatment
D Fineberg, KAM Jandeleit-Dahm… - Nature Reviews …, 2013 - cir.nii.ac.jp
Diabetic nephropathy: diagnosis and treatment | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
Diabetic nephropathy: diagnosis and treatment
D Fineberg, KAM Jandeleit-dahm… - Nature Reviews …, 2013 - search.proquest.com
Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
Diabetic nephropathy: diagnosis and treatment
D Fineberg, KAM Jandeleit-Dahm… - Nature Reviews …, 2013 - nature.com
Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
[PDF][PDF] Diabetic nephropathy: diagnosis and treatment
D Fineberg, KAM Jandeleit-Dahm, ME Cooper - 2013 - edisciplinas.usp.br
Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
Diabetic nephropathy: diagnosis and treatment
D Fineberg, KAM Jandeleit-Dahm… - Nature Reviews …, 2013 - go.gale.com
Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
Diabetic nephropathy: diagnosis and treatment.
D Fineberg, KA Jandeleit-Dahm… - Nature reviews …, 2013 - europepmc.org
Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
Diabetic nephropathy: diagnosis and treatment
D Fineberg, KAM Jandeleit-Dahm… - Nature reviews …, 2013 - pubmed.ncbi.nlm.nih.gov
Nephropathy remains a major cause of morbidity and a key determinant of mortality in
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …
patients with type 1 or type 2 diabetes mellitus. Research is ongoing to identify biomarkers …